Bakker BM - Search Results

1

Modeling response of glycolysis in S. cerevisiae cells harvested at diauxic shift.

Albers E, Bakker BM, Gustafsson L. Albers E, et al. Among authors: bakker bm. Mol Biol Rep. 2002;29(1-2):119-23. doi: 10.1023/a:1020349023158. Mol Biol Rep. 2002. PMID: 12241040

2

Loss of fermentative capacity in baker's yeast can partly be explained by reduced glucose uptake capacity.

Rossell S, van der Weijden CC, Kruckeberg A, Bakker BM, Westerhoff HV. Rossell S, et al. Among authors: bakker bm. Mol Biol Rep. 2002;29(1-2):255-7. doi: 10.1023/a:1020398401293. Mol Biol Rep. 2002. PMID: 12241067

3

DNA supercoiling by gyrase is linked to nucleoid compaction.

Stuger R, Woldringh CL, van der Weijden CC, Vischer NO, Bakker BM, van Spanning RJ, Snoep JL, Westerhoff HV. Stuger R, et al. Among authors: bakker bm. Mol Biol Rep. 2002;29(1-2):79-82. doi: 10.1023/a:1020318705894. Mol Biol Rep. 2002. PMID: 12241080

4

Network-based selectivity of antiparasitic inhibitors.

Bakker BM, Assmus HE, Bruggeman F, Haanstra JR, Klipp E, Westerhoff H. Bakker BM, et al. Mol Biol Rep. 2002;29(1-2):1-5. doi: 10.1023/a:1020397513646. Mol Biol Rep. 2002. PMID: 12241036 No abstract available.

5

Yeast glycolytic oscillations that are not controlled by a single oscillophore: a new definition of oscillophore strength.

Reijenga KA, van Megen YM, Kooi BW, Bakker BM, Snoep JL, van Verseveld HW, Westerhoff HV. Reijenga KA, et al. Among authors: bakker bm. J Theor Biol. 2005 Feb 7;232(3):385-98. doi: 10.1016/j.jtbi.2004.08.019. J Theor Biol. 2005. PMID: 15572063

6

Mixed and diverse metabolic and gene-expression regulation of the glycolytic and fermentative pathways in response to a HXK2 deletion in Saccharomyces cerevisiae.

Rossell S, Lindenbergh A, van der Weijden CC, Kruckeberg AL, van Eunen K, Westerhoff HV, Bakker BM. Rossell S, et al. Among authors: bakker bm. FEMS Yeast Res. 2008 Feb;8(1):155-64. doi: 10.1111/j.1567-1364.2007.00282.x. Epub 2007 Jul 27. FEMS Yeast Res. 2008. PMID: 17662056

7

Metabolic control analysis to identify optimal drug targets.

Hornberg JJ, Bruggeman FJ, Bakker BM, Westerhoff HV. Hornberg JJ, et al. Among authors: bakker bm. Prog Drug Res. 2007;64:171, 173-89. doi: 10.1007/978-3-7643-7567-6_7. Prog Drug Res. 2007. PMID: 17195475 Review.

8

Drug-efficacy depends on the inhibitor type and the target position in a metabolic network--a systematic study.

Gerber S, Assmus H, Bakker B, Klipp E. Gerber S, et al. J Theor Biol. 2008 Jun 7;252(3):442-55. doi: 10.1016/j.jtbi.2007.09.027. Epub 2007 Sep 26. J Theor Biol. 2008. PMID: 17981303

9

Systems biology and the reconstruction of the cell: from molecular components to integral function.

Bruggeman FJ, Rossell S, Van Eunen K, Bouwman J, Westerhoff HV, Bakker B. Bruggeman FJ, et al. Subcell Biochem. 2007;43:239-62. doi: 10.1007/978-1-4020-5943-8_11. Subcell Biochem. 2007. PMID: 17953397 Review. No abstract available.

10

Training of yeast cell dynamics.

Reijenga KA, Bakker BM, van der Weijden CC, Westerhoff HV. Reijenga KA, et al. Among authors: bakker bm. FEBS J. 2005 Apr;272(7):1616-24. doi: 10.1111/j.1742-4658.2005.04582.x. FEBS J. 2005. PMID: 15794749 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

136 results

Search Page